Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:aimsTo |
cancer
autoimmune diseases |
| gptkbp:CEO |
gptkb:Dr._Michael_McGarrity
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaboratesWith |
pharmaceutical companies
|
| gptkbp:develops |
T-cell therapies
|
| gptkbp:focusesOn |
cell therapy
|
| gptkbp:founded |
2015
|
| gptkbp:hasCollaboratedWith |
clinical research organizations
|
| gptkbp:hasCollaborationsWith |
academic institutions
|
| gptkbp:hasFilm |
transforming treatment paradigms
|
| gptkbp:hasFunding |
venture capital
|
| gptkbp:hasGoals |
expand market presence
|
| gptkbp:hasLocalCuisine |
Phase 1
Phase 2 Phase 3 |
| gptkbp:hasMember |
experienced professionals
|
| gptkbp:hasMission |
improve patient outcomes
|
| gptkbp:hasOccupation |
various countries
health initiatives |
| gptkbp:hasParticipatedIn |
conferences
|
| gptkbp:hasPartnershipsWith |
biotech_firms
|
| gptkbp:hasPriorityDate |
various indications
|
| gptkbp:hasProductLine |
multiple drug candidates
|
| gptkbp:hasResearchFocus |
immunotherapy
|
| gptkbp:hasSibling |
a strong brand
|
| gptkbp:hasSpecialty |
patents
commitment to ethics |
| gptkbp:headquarters |
gptkb:Scotland
|
| https://www.w3.org/2000/01/rdf-schema#label |
TC Biopharma
|
| gptkbp:isActiveIn |
global markets
|
| gptkbp:isAttendedBy |
scientific research
unmet medical needs |
| gptkbp:isBasedOn |
gptkb:United_Kingdom
|
| gptkbp:isEngagedIn |
research and development
patient advocacy public relations. |
| gptkbp:isEnhancedBy |
patient access to therapies
|
| gptkbp:isFocusedOn |
sustainable practices
patient-centric solutions |
| gptkbp:isInvolvedIn |
clinical research
|
| gptkbp:isKnownFor |
innovative therapies
|
| gptkbp:isLocatedIn |
advanced technologies
data analytics collaborative environments |
| gptkbp:isPartOf |
yes
biopharmaceutical industry |
| gptkbp:isPromotedBy |
healthcare_innovation
|
| gptkbp:isRecognizedFor |
scientific advancements
|
| gptkbp:isSetIn |
new partnerships
|
| gptkbp:isSupportedBy |
investors
|
| gptkbp:isUtilizedFor |
technology advancements
value for stakeholders |
| gptkbp:isVisitedBy |
next-generation therapies
|
| gptkbp:operatesIn |
regenerative medicine
|
| gptkbp:partnerships |
various research institutions
|
| gptkbp:tradedOn |
gptkb:London_Stock_Exchange
|
| gptkbp:usesTechnology |
genetic engineering
|